Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TNFSF8 is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. Additionally we are shipping Tumor Necrosis Factor (Ligand) Superfamily, Member 8 Kits (38) and Tumor Necrosis Factor (Ligand) Superfamily, Member 8 Proteins (22) and many more products for this protein.
Showing 10 out of 108 products:
Mouse (Murine) Monoclonal TNFSF8 Primary Antibody for FACS - ABIN2656941
Bowen, Lee, Miragliotta, Nam, Podack: Structure and expression of murine CD30 and its role in cytokine production. in Journal of immunology (Baltimore, Md. : 1950) 1996
Show all 8 references for ABIN2656941
Mouse (Murine) Monoclonal TNFSF8 Primary Antibody for FACS, IF - ABIN2663049
Shanebeck, Maliszewski, Kennedy, Picha, Smith, Goodwin, Grabstein: Regulation of murine B cell growth and differentiation by CD30 ligand. in European journal of immunology 1995
Show all 7 references for ABIN2663049
Mouse (Murine) Monoclonal TNFSF8 Primary Antibody for FACS - ABIN2478609
Burchenal: The relevance of research in tropical medicine today. in Bulletin of the New York Academy of Medicine 1975
Show all 3 references for ABIN2478609
Mouse (Murine) Monoclonal TNFSF8 Primary Antibody for FACS - ABIN119139
Shimozato, Takeda, Yagita, Okumura: Expression of CD30 ligand (CD153) on murine activated T cells. in Biochemical and biophysical research communications 1999
Human Polyclonal TNFSF8 Primary Antibody for ELISA, WB - ABIN1533700
Smith, Gruss, Davis, Anderson, Farrah, Baker, Sutherland, Brannan, Copeland, Jenkins: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. in Cell 1993
Data indicate that CD30L/CD30 (show TNFRSF8 Antibodies) axis plays a modulatory role in the pathogenesis of experimental autoimmune encephalomyelitis (EAE).
Altered expression of CD30L and IL-3 (show Il3 Antibodies) may be potential biomarkers for hepatotoxicity induced by D. bulbifera.
role in the maintenance and activation of IL-17A (show IL17A Antibodies)-producing gammadelta T cells
Interference of the CD30 (show TNFRSF8 Antibodies)-CD30L pathway reduces atherosclerosis development.
It is shown here that CD30L knock out (KO) mice are highly susceptible to primary infection with Listeria monocytogenes as assessed by the survival rate.
role of CD30L/CD30 (show TNFRSF8 Antibodies) interactions in allergic rhinitis; results suggest that CD30L plays an important role in allergic rhinitis
Modulation of CD30L/CD30 (show TNFRSF8 Antibodies) signaling by soluble CD30 (show TNFRSF8 Antibodies) could be a novel biological therapy for inflammatory diseases associated with Th17 responses.
Studies demonstrate that CD30L/CD30 (show TNFRSF8 Antibodies) signaling executed by the T-T cell interaction plays a critical role in Th17 cell differentiation.
Characterization of the murine CD30 ligand (CD153) gene: gene structure and expression.
CD30L is required for generation of long-lived memory CD8 (show CD8A Antibodies)+ T cells; CD30L signaling triggers homing receptors for T(central memory) cells.
circulant sCD30L is functionally active and that it may favor persistence of active inflammation by inducing apoptosis of CD30 (show TNFRSF8 Antibodies)(+)T cells, known to down-modulate inflammation in rheumatoid synovitis.
TNFSF8 is an important leprosy T1R susceptibility gene.
The heritability of IgA levels is moderate and can partly be attributable to common variation in the CD30L locus.
soluble apoptosis markers as sFas-L, Caspase-9 (show CASP9 Antibodies), Caspase-8 (show CASP8 Antibodies) and sCD153 were significantly higher in stage III obesity patients compared obese patients without food allergy
a novel and unexpected role for CD30 (show TNFRSF8 Antibodies)/CD30L that contributes to proinflammatory immune responses
The TNFSF8 polymorphisms rs927374 and rs2295800 were associated with neutrophil count. This finding suggests that post-MI inflammatory response is genetically modulated.
Positional candidate gene screening in the SPA2 locus allowed us to identify and replicate an association between a rare SNP located in TNFSF8 and spondylarthritis.
a possible role of novel TNFSF8 variants in susceptibility to lung cancer.
capability to up-regulate expression of CD30 (show TNFRSF8 Antibodies), release of soluble CD30 (show TNFRSF8 Antibodies) and production of IL-4 (show IL4 Antibodies) in pre-activated T cells upon co-culture
only in a subset of both benign and malignant thyroid nodules the interleukin-6/interleukin-6 (show IL6 Antibodies) receptor (show IL6ST Antibodies) signal could be induced by the CD30 ligand/CD30 (show TNFRSF8 Antibodies)
The protein encoded by this gene is a cytokine that belongs to the tumor necrosis factor (TNF) ligand family. This cytokine is a ligand for TNFRSF8/CD30, which is a cell surface antigen and a marker for Hodgkin lymphoma and related hematologic malignancies. The engagement of this cytokine expressed on B cell surface plays an inhibitory role in modulating Ig class switch. This cytokine was shown to enhance cell proliferation of some lymphoma cell lines, while to induce cell death and reduce cell proliferation of other lymphoma cell lines. The pleiotropic biologic activities of this cytokine on different CD30+ lymphoma cell lines may play a pathophysiologic role in Hodgkin's and some non-Hodgkin's lymphomas. Two transcript variants encoding different isoforms have been found for this gene.
tumor necrosis factor (ligand) superfamily, member 8
, CD30 antigen ligand
, CD30 ligand
, tumor necrosis factor ligand superfamily member 8
, CD153 antigen